D20054;LITT for Spine Tumors

Part of paid clinical trials in Lebanon, New Hampshire.

Sponsor
Dartmouth-Hitchcock Medical Center
Study ID
NCT06548061
Status
Recruiting
Apply to this trial

Conditions

  • Spinal Metastases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ClearPoint Prism — DEVICE
    Spine laser interstitial therapy used instead of open decompression followed by spine stereotactic radiosurgery (SSRS).

Study Details

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.

Key Dates

Start date
May 16, 2024
Status verified
Feb 2026
Primary completion
Jun 1, 2029
Completion
Jun 1, 2029

Study Design

Enrollment
25 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Spinal Laser Interstitial Thermal Therapy (sLITT)
    Patients will undergo surgery utilizing the Visualase Thermal Therapy System (Medtronic) device.

Primary Outcome Measure

Local tumor control [ Time Frame: Local control rate at 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Dartmouth HealthLebanonNew Hampshire03766
Lauren Sinks, MPH
[email protected]
(603) 653-9021

Find similar trials in Lebanon, NH

By research site
Dartmouth Health· Lebanon, NH

Related Studies